Rhinomed records strong sales growth

THE ROADHOUSE PHARMACY: Respiratory and nasal technology company Rhinomed Limited (ASX: RNO) has recorded $201,000 in sales of its lead Turbine technology for the June quarter – up from $9,000 in the previous quarter.

The company attributed the growth to growing penetration of the technology within the Australian cycling community and with wholesalers.

The company has been peddling a strategic marketing campaign, which it said has resulted in growth of the Turbine’s social media profile and the appointment of a high profile cycling ambassador in former Tour de France green jersey winner Baden Cooke to endorse the product.

The company said it had anticipated a positive sales upswing, following the product’s January 2014 launch and the introduction of the Turbine technology to potential user groups, with an initial focus on the sports cycling community.

“We are actively promoting our novel technology to those sporting groups who can gain immediate benefit,” Rhinomed CEO Michael Johnson said in the company’s announcement to the Australian Securities Exchange.

“Our first target market was the Australian cycling community.

“Exposing our device and its benefits to this group has resulted in our database growing to over 12,000 cycling enthusiasts.

“These positive sales figures demonstrate our strategy is steadily gaining traction in this important arena.”

Rhinomed appointed Cooke as a Turbine brand ambassador in Europe in May this year and he is actively promoting the Turbine technology to European cyclists, particularly during the Tour de France, which is now underway.

“The Turbine is proving to be a valuable solution to anyone, anywhere who finds themselves short of breath,” Johnson said.

“Introducing the Turbine to the Australian cycling market was only the beginning, we are increasingly focused on global opportunities.”

Website: www.rhinomed.com.au